Eli Lilly and Co at Bernstein Strategic Decisions Conference Transcript
Hi, everyone. Thank you so much for being with us today. It is my pleasure to be sharing the stage with Dan Skovronsky, Chief Scientific Officer as well as Chief Product Officer at Eli Lilly. We will be having hopefully an insightful conversation on the company and particularly given his role kind of the approach to R&D at Lilly and how that continues to evolve.
While I have a long list of questions, and I'm really excited to ask Dan, I also recognize that there's a bunch of people in this room that also have questions that might differ from mine. So we do have the Pigeonhole app. Please feel free to add any questions that you have of interest into that app, and I'll do my best to work them into the conversation. So please dive into that so that we get kind of the most robust conversation we can today.
Questions & Answers
So with that, I want to start with a little bit of scene setting perhaps, Eli Lilly is
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
